Atıf İçin Kopyala
Karnak D., Beder S., KAYACAN O., İBİŞ E., Oflaz G.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.28, sa.6, ss.586-590, 2005 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
28
Sayı:
6
-
Basım Tarihi:
2005
-
Doi Numarası:
10.1097/01.coc.0000177915.51805.6e
-
Dergi Adı:
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.586-590
-
Anahtar Kelimeler:
neuron-specific enolase, bronchoalveolar lavage fluid, lung cancer, tumor marker, SERUM TUMOR-MARKERS, BRONCHOALVEOLAR LAVAGE, PROGNOSTIC VALUE, CARCINOEMBRYONIC ANTIGEN, DISEASE EXTENT, NSE, THERAPY, CHEMOTHERAPY, CYFRA-21-1, CARCINOMA
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objective: Serum and bronchoalveolar lavage fluid (BALF) neuronspecific enolase (NSE) levels in lung cancer have been investigated widely; however, their diagnostic values have not yet been clarified. The authors investigated the diagnostic validity of NSE in BALF and serum in lung cancer. Materials and